Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation

Experimental Neurology

Volumn 218, Issue 1, 2009, Pages 64-74

  Schonberg, David L ^a   McTigue, Dana M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Myelin; Polydendrocytes; Precursor; Spinal cord injury; Toll like receptor (TLR); Trauma

Indexed keywords

DEFERASIROX; FERRITIN; IRON; IRON CHELATING AGENT; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; FEMALE; IRON STORAGE; MACROPHAGE ACTIVATION; MICROGLIA; MICROINJECTION; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; STEM CELL;

ANIMALS; ANTIGENS; ANTIGENS, CD11B; BENZOIC ACIDS; BROMODEOXYURIDINE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERRITINS; GENE EXPRESSION REGULATION; INJECTIONS, SPINAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON; IRON CHELATING AGENTS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; OLIGODENDROGLIA; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRIAZOLES;

EID: 67349129060     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.04.005     Document Type: Article

References (59)

1. Adamo A.M., Paez P.M., Escobar Cabrera O.E., Wolfson M., Franco P.G., Pasquini J.M., and Soto E.F. Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin. Exp.Neurol. 198 (2006) 519-529
2. Aravalli R.N., Peterson P.K., and Lokensgard J.R. Toll-like receptors in defense and damage of the central nervous system. J. Neuroimmune. Pharmacol. 2 (2007) 297-312
3. Beard J.L., Wiesinger J.A., and Connor J.R. Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev. Neurosci. 25 (2003) 308-315
4. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., and Becker G. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79 (2001) 225-236
5. Cappellini D.M. Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther. Clin. Risk. Manag. 3 (2007) 291-299
6. Chen K., Huang J., Gong W., Iribarren P., Dunlop N.M., and Wang J.M. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 7 (2007) 1271-1285
7. Connor J.R., and Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 17 (1996) 83-93
8. Connor J.R., Pavlick G., Karli D., Menzies S.L., and Palmer C. A histochemical study of iron-positive cells in the developing rat brain. J. Comp. Neurol. 355 (1995) 111-123
9. Crichton R.R., Wilmet S., Legssyer R., and Ward R.J. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 91 (2002) 9-18
10. Demougeot C., Van H.M., Bertrand N., Prigent-Tessier A., Mossiat C., Beley A., and Marie C. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the rat photothrombotic ischemic stroke model. J. Pharmacol. Exp. Ther. 311 (2004) 1080-1087
11. Dringen R., Bishop G.M., Koeppe M., Dang T.N., and Robinson S.R. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res. 32 (2007) 1884-1890
12. Fahmy M., and Young S.P. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem. J. 296 Pt 1 (1993) 175-181
13. Felts P.A., Woolston A.M., Fernando H.B., Asquith S., Gregson N.A., Mizzi O.J., and Smith K.J. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128 (2005) 1649-1666
14. Figueiredo R.T., Fernandez P.L., Mourao-Sa D.S., Porto B.N., Dutra F.F., Alves L.S., Oliveira M.F., Oliveira P.L., Graca-Souza A.V., and Bozza M.T. Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282 (2007) 20221-20229
15. Filipovic R., and Zecevic N. Lipopolysaccharide affects Golli expression and promotes proliferation of oligodendrocyte progenitors. Glia 49 (2005) 457-466
16. Fillebeen C., Dehouck B., Benaissa M., Dhennin-Duthille I., Cecchelli R., and Pierce A. Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier. J. Neurochem. 73 (1999) 2491-2500
17. Finch C.A., and Huebers H. Perspectives in iron metabolism. N. Engl. J. Med. 306 (1982) 1520-1528
18. Ge Y., Jensen J.H., Lu H., Helpern J.A., Miles L., Inglese M., Babb J.S., Herbert J., and Grossman R.I. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am. J. Neuroradiol. 28 (2007) 1639-1644
19. Glezer I., Lapointe A., and Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20 (2006) 750-752
20. Glezer I., Chernomoretz A., David S., Plante M.M., and Rivest S. Genes involved in the balance between neuronal survival and death during inflammation. PLoS ONE 2 (2007) e310
21. Goos M., Lange P., Hanisch U.K., Prinz M., Scheffel J., Bergmann R., Ebert S., and Nau R. Fibronectin is elevated in the cerebrospinal fluid of patients suffering from bacterial meningitis and enhances inflammation caused by bacterial products in primary mouse microglial cell cultures. J. Neurochem. 102 (2007) 2049-2060
22. Hibbs Jr. J.B., Taintor R.R., and Vavrin Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem. Biophys. Res. Commun. 123 (1984) 716-723
23. Howard C.V., and Reed M.G. Unbiased Stereology: Three-Dimensional Measurement in Microscopy (1998), Springer-Verlag, New York
24. Huebers H.A., and Finch C.A. The physiology of transferrin and transferrin receptors. Physiol. Rev. 67 (1987) 520-582
25. Hulet S.W., Heyliger S.O., Powers S., and Connor J.R. Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J. Neurosci. Res. 61 (2000) 52-60
26. Kigerl K.A., McGaughy V.M., and Popovich P.G. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 494 (2006) 578-594
27. Kuhlow C.J., Krady J.K., Basu A., and Levison S.W. Astrocytic ceruloplasmin expression, which is induced by IL-1beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor. Glia 44 (2003) 76-84
28. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., and Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22 (2002) 2478-2486
29. Levine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760 (1997) 298-303
30. Liu D., Liu J., Sun D., Alcock N.W., and Wen J. Spinal cord injury increases iron levels: catalytic production of hydroxyl radicals. Free Radic. Biol. Med. 34 (2003) 64-71
31. Ludwiczek S., Aigner E., Theurl I., and Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101 (2003) 4148-4154
32. Mao Y., and Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 24 (2005) 389-399
33. Masuda T., Hida H., Kanda Y., Aihara N., Ohta K., Yamada K., and Nishino H. Oral administration of metal chelator ameliorates motor dysfunction after a small hemorrhage near the internal capsule in rat. J. Neurosci. Res. 85 (2007) 213-222
34. McTigue D.M., and Tripathi R.B. The life, death and replacement of oligodendrocytes in the adult central nervous system. J. Neurochem. 107 (2008) 1-19
35. Mehindate K., Sahlas D.J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S., and Schipper H.M. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 77 (2001) 1386-1395
36. Moura E., Noordermeer M.A., Verhoeven N., Verheul A.F., and Marx J.J. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 92 (1998) 2511-2519
37. Neufeld E.J. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 107 (2006) 3436-3441
38. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., Chow J.C., and Strauss J.F. The extra domain A of fibronectin activates toll-like receptor 4. J. Biol. Chem. 276 (2001) 10229-10233
39. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., and Connor J.R. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J. Neurosci. Res. 77 (2004) 681-689
40. Pasinetti G.M., Nichols N.R., Tocco G., Morgan T., Laping N., and Finch C.E. Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience 54 (1993) 893-907
41. Peyssonnaux C., Zinkernagel A.S., Datta V., Lauth X., Johnson R.S., and Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107 (2006) 3727-3732
42. Pinero D.J., Hu J., Cook B.M., Scaduto Jr. R.C., and Connor J.R. Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim. Biophys. Acta 1497 (2000) 279-288
43. Popovich P.G., Guan Z., McGaughy V., Fisher L., Hickey W.F., and Basso D.M. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61 (2002) 623-633
44. Quintana C., Bellefqih S., Laval J.Y., Guerquin-Kern J.L., Wu T.D., Avila J., Ferrer I., Arranz R., and Patino C. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 153 (2006) 42-54
45. Rathore K.I., Kerr B.J., Redensek A., Lopez-Vales R., Jeong S.Y., Ponka P., and David S. Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J. Neurosci. 1273 6-1 (2008) 28 2747
46. Rogers J.T. Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 87 (1996) 2525-2537
47. Rouault T.A., and Cooperman S. Brain iron metabolism. Semin. Pediatr. Neurol. 13 (2006) 142-148
48. Schonberg D.L., Popovich P.G., and McTigue D.M. Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J. Neuropathol. Exp. Neurol. 66 (2007) 1124-1135
49. Schultke E., Kendall E., Kamencic H., Ghong Z., Griebel R.W., and Juurlink B.H. Quercetin promotes functional recovery following acute spinal cord injury. J. Neurotrauma 20 (2003) 583-591
50. Simmons D.A., Casale M., Alcon B., Pham N., Narayan N., and Lynch G. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55 (2007) 1074-1084
51. Smith M.A., Harris P.L., Sayre L.M., and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A 94 (1997) 9866-9868
52. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., and Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279 (2004) 17079-17084
53. Torti F.M., and Torti S.V. Regulation of ferritin genes and protein. Blood 99 (2002) 3505-3516
54. Torti S.V., Kwak E.L., Miller S.C., Miller L.L., Ringold G.M., Myambo K.B., Young A.P., and Torti F.M. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J. Biol. Chem. 263 (1988) 12638-12644
55. Weiss G. Iron and immunity: a double-edged sword. Eur. J. Clin. Invest 32 Suppl. 1 (2002) 70-78
56. Weiss G., Bogdan C., and Hentze M.W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 158 (1997) 420-425
57. Wu J., Hua Y., Keep R.F., Nakamura T., Hoff J.T., and Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34 (2003) 2964-2969
58. Zhang J., Stanton D.M., Nguyen X.V., Liu M., Zhang Z., Gash D., and Bing G. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits. Neuroscience 135 (2005) 829-838
59. Zhang X., Surguladze N., Slagle-Webb B., Cozzi A., and Connor J.R. Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54 (2006) 795-804